Stockreport

The Oncology Institute Reaffirms 2025 Guidance and Provides Preliminary 2026 Outlook

The Oncology Institute, Inc.  (TOI) 
PDF CERRITOS, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based oncology groups [Read more]